Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
BMED
133
HOLDINGS
24%
ALSO IN HRTS
HRTS
43
HOLDINGS
58%
ALSO IN BMED
SECTOR DRIFT (BMED minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.6% | 3.3% | 3.3% |
|
BOSTON SCIENTIFIC CORP | 5.3% | 3.1% | 3.1% |
|
ABBVIE INC | 3.1% | 2.9% | 2.9% |
|
ABBOTT LABORATORIES | 2.6% | 3.7% | 2.6% |
 |
MEDTRONIC PLC | 2.3% | 3.0% | 2.3% |
BMED Overweight Relative to HRTS
 |
ARGENX SE ADR | 4.2% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
LONZA GROUP AG-REG | 3.1% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
UCB SA | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.2% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.2% |
|
NATERA INC | 1.8% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% |
|
GUARDANT HEALTH, INC. | 1.7% |
BMED Underweight Relative to HRTS
|
ELI LILLY & CO | -10.4% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.7% |
|
UNITEDHEALTH GROUP INC | -4.4% |
 |
ASTRAZENECA PLC | -4.2% |
|
JOHNSON & JOHNSON | -3.2% |
|
NOVARTIS AG | -2.9% |
|
VERTEX PHARMACEUTICALS INC | -2.5% |
 |
NOVO NORDISK A/S-B | -2.5% |
|
MERCK & CO. INC. | -2.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.4% |